# First-in-Human Safety Study for Fractomer™ Biomatrix

> **NCT07151638** · NA · COMPLETED · sponsor: **inSoma Bio, Inc.** · enrollment: 2 (actual)

## Conditions studied

- Soft Tissue
- Soft Tissue Defects
- Subcutaneous Injection

## Interventions

- **DEVICE:** Implantation (injection) of a new biomatrix for soft tissue support.

## Key facts

- **NCT ID:** NCT07151638
- **Lead sponsor:** inSoma Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-11
- **Primary completion:** 2025-10-22
- **Final completion:** 2025-11-05
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07151638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07151638, "First-in-Human Safety Study for Fractomer™ Biomatrix". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT07151638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*